Pharma Marketing Network

I recently received this simple tweet from @JNJComm (Johnson and Johnson's official corporate Twitter account): #JNJ is pleased to rank 12th among @FortuneMagazine’s most admired...

The Geneva-based International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) expanded its practice code to cover all interactions with health-care professionals, medical institutions and...

I received an e-mail today announcing the launch of "Google Pharmacy" that promised it will "improve the Google experience for people buying pills and...

I have documented the rise and fall of several pharma celebrity spokespeople (see, for example, this list) . This past week two such celebrities...

"Hope on the Horizon," is the title of today's FDAVoice blog post by Margaret Hamburg, M.D., FDA Commissioner. The post (here) highlighted a presentation...

Alex Gorsky will have to address trouble at J&J's consumer business when he becomes CEO, notes the Wall Street Journal (see here). Sure, "those who...

Often, when proponents of pharma eMarketing get together at industry conferences, or cry into their beers at receptions afterward, they lament the fact that...

A 'recession' in pharma marketing is likely considering the well-known 'patent cliff' that's currently in progress; ie, blockbuster drugs with a combined $170 billion in annual sales will go off-patent by 2015. That means even less mass media advertising and more digital advertising. But 'more digital advertising' does not mean that much more money will be spent in the digital arena. That's because of social media, where it's virtually free to advertise!

Practically every pharmaceutical company has one or more apps. The ones I am interested in are apps designed to help doctors in their diagnosis of patients. Big among these are the

In a blog post provocatively titled 'An App for That, But For How Much Longer?', PhRMA's Kate Connors agreed with a Washington Times op-ed piece that suggested the FDA will soon require apps such as medication prescription renewal reminders and blood glucose level tracking functions to be regulated as medical devices. The op-ed author, Joel White, executive director of the Health IT Now Coalition, suggests that this effort would lead to increased costs as well as constraints on user access to these apps, which 'may cause developers to move on to other, less burdensome endeavors.' 'In the end, this could hinder the way that patients can actively improve their own care,' said Conners. Is this fear warranted? Are there apps that SHOULD be regulated by the FDA? Read this article and find out.